Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders

Szymanski, Ludwik S.; King, Bryan H.

doi:10.1016/s0890-8567(99)80002-1

Cited by 114 publications

(41 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, treatment guidelines for people with mental retardation are clear with respect to the need for psychopharmacological interventions to be diagnosis-driven. 32,35,36 Virtually all of the individuals living in community care facilities had personal physicians, yet only half of those with personal physicians were protected against tetanus, fewer than half were protected against hepatitis B, and fewer than three-quarters had received influenza vaccine during the previous year. Moreover, for the women in the study, including those in group facilities, cervical cancer screening rates were inadequate.…”

Section: Discussionmentioning

confidence: 99%

The Quality of Health Care for Adults with Developmental Disabilities

Lewis

Leake

et al. 2002

Public Health Reports

View full text Add to dashboard Cite

SYNOPSISObjective. The purpose of this study was to determine the health status of adults with developmental disabilities residing in community settings and the quality of the preventive, medical, dental, and psychiatric services they receive.Methods. Data were collected on a sample of 353 adults residing in Los Angeles, California, in 1997. Historical data were obtained from study subjects or caregivers, physical and dental examinations were performed, blood was drawn for analysis, and a psychiatrist reviewed medical records for reports of psychiatric diagnoses and consultations.Results. Health markers, such as rates of obesity, and laboratory test results of routine screening panels including blood cell counts, hemoglobin, and hematocrits; blood concentrations of liver enzymes and other enzymes, cholesterol, and tryglycerides; and urinalyses were within normal limits for an adult population. However, preventive services were notably lacking, especially for individuals living at home. Fewer than half of the study subjects had received influenza vaccine; only a third of those living alone or with family or friends had received this vaccination. Chart audits revealed that about a third received psychotropic medications, but only 24% of these individuals had psychiatric consultations noted in their record. Further, 36% of this medicated group received psychotropic drugs without any identifiable diagnosis, and simultaneous receipt of two or more antipsychotics was not uncommon.Conclusions. Given that the U.S. health care system fails to ensure the provision of preventive services for all people, including the developmentally disabled, a systematic overhaul is necessary to establish an effective quality assurance program that will provide preventive medical, dental, and psychiatric services for people with developmental disabilities.

show abstract

Section: Discussionmentioning

confidence: 99%

The Quality of Health Care for Adults with Developmental Disabilities

Lewis

Leake

et al. 2002

Public Health Reports

View full text Add to dashboard Cite

show abstract

“…Diagnostic criteria for psychiatric disorders have been adapted as needed for individuals with intellectual disabilities [Fletcher et al, 2007], and consensus guidelines have been developed for the use of psychotropic medications in people with intellectual disabilities in general [Reiss and Aman, 1989;Szymanski and King, 1999]. Clinical trials have been conducted or are now underway that target older adults with dementia [Prasher et al, 2002;Aisen et al, 2005].…”

Section: Efficacy Of Interventions or Treatments That Both Reduce Symmentioning

confidence: 99%

Psychiatric and behavioral disorders in persons with Down syndrome

Dykens

2007

Ment. Retard. Dev. Disabil. Res. Rev.

210

150

View full text Add to dashboard Cite

Similar to the state of the broader intellectual disabilities field, many gaps exist in the research and treatment of mental health concerns in people with Down syndrome. This review summarizes key findings on the type and prevalence of behavior and emotional problems in children, adolescents, and adults with Down syndrome. Such findings include relatively low rates of severe problems in children, and well-documented risks of depression and Alzheimer's disease in older adults. The review also considers emerging data on autism, and the paucity of studies on adolescents. Three next steps for research are highlighted, including a need to: (1) connect research on psychiatric status and diagnoses across developmental periods, including adolescence, and to examine such associated processes as sociability, anxiety and attention; (2) unravel complicated biopsycho-social risk and protective factors that serve to increase or diminish psychopathology; and (3) identify evidence-based treatments that both reduce distressful symptoms and enhance well-being in individuals with Down syndrome.

show abstract

“…Persons with ID have a limited ability to express abstract thoughts and feelings or to answer questions about the onset, duration, frequency, and severity of symptoms, and in addition show acquiescence bias to interview questions (Moss, 1999). These difficulties have led some to adapt the standard DSM and ICD criteria for use with ID (King, DeAntonio, McCracken, Forness, & Ackerland, 1994;Szymanski & King, 1999). Others have designed interview schedules specifically for this population, including the Psychiatric Assessment Schedule for Adults with Developmental Disability (PAS-ADD or mini-PAS-ADD; Moss, Prosser, & Goldberg, 1996;Moss, Ibbotson, Prosser, Goldberg, Patel, & Simpson, 1997).…”

Section: A Clinical-medical Approachmentioning

confidence: 99%

Psychopathology in Children and Adolescents with Intellectual Disability: Measurement, Prevalence, Course, and Risk

Wallander

Dekker

Koot

2003

International Review of Research in Mental Retardation

View full text Add to dashboard Cite

Children, including adolescents, with intellectual disability (ID) are at higher risk than children without ID for developing psychopathology, a term we use to subsume similar terms such as mental illness or health problems, psychiatric or behavior disorders, and behavior and emotional problems. Psychopathology in children with ID is also more likely to go unrecognized and untreated. Psychopathology may have a major effect on their general well-being, personal independence, school and social functioning, and quality of life, as well as on family and other caregivers. The combination of ID and psychopathology can also give rise to further stigmatization, prejudices, and misunderstandings, which may decrease the likelihood of full integration. INTERNATIONAL REVIEW OF RESEARCH IN 93

show abstract

Practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders

Cited by 114 publications

References 46 publications

The Quality of Health Care for Adults with Developmental Disabilities

The Quality of Health Care for Adults with Developmental Disabilities

Psychiatric and behavioral disorders in persons with Down syndrome

Psychopathology in Children and Adolescents with Intellectual Disability: Measurement, Prevalence, Course, and Risk

Contact Info

Product

Resources

About